Detalles de la búsqueda
1.
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Cardiovasc Diabetol;
22(1): 143, 2023 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349722
2.
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
Cardiovasc Diabetol;
20(1): 4, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33397376
3.
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Cardiovasc Diabetol;
19(1): 110, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646498
4.
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
Diabetes Ther;
12(9): 2499-2515, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34357559
5.
Two cases with Hb Andrew-Minneapolis showing high or low-normal HbA1c levels depending on the measurement method.
Clin Chim Acta;
501: 229-233, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711758
6.
Neuropsychiatric Immune-related Adverse Events Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma and Systemic Lupus Erythematosus.
Intern Med;
59(4): 569-572, 2020 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666468
7.
A case of monoclonal gammopathy of undetermined significance with abnormal low levels of plasma glycated albumin by M protein.
Clin Chim Acta;
487: 337-340, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30317021
8.
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
Diabetes Ther;
8(5): 999-1013, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28864997
9.
The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells.
J Diabetes Complications;
20(5): 336-42, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16949522
10.
Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.
Arterioscler Thromb Vasc Biol;
24(4): 658-63, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-14751809
11.
Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes.
Ann Clin Biochem;
52(Pt 1): 76-81, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24604630
12.
Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts.
Endocrinology;
143(3): 820-8, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11861503
13.
RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor alpha on interleukin-6 production in vascular endothelial cells.
J Steroid Biochem Mol Biol;
81(2): 141-6, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12137803
14.
Effectiveness of metformin and lifestyle interventions as an initial treatment in Japanese patients with newly diagnosed type 2 diabetes: a prospective observational study.
J Med Invest;
59(1-2): 166-73, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22450005
15.
Effects of pitavastatin on serum lipids and high sensitivity C-reactive protein in type 2 diabetic patients.
J Atheroscler Thromb;
16(5): 546-52, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19729863
16.
Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transduction.
Biochem Biophys Res Commun;
328(4): 953-61, 2005 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15707970
17.
New analytical method for pancreas and liver regeneration: normalization of streptozotocin-induced hyperglycemia by retrograde injection of insulin producing cells.
Endocr J;
49(4): 449-57, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12402977
18.
Runx2 deficiency in chondrocytes causes adipogenic changes in vitro.
J Cell Sci;
117(Pt 3): 417-25, 2004 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-14702386
Resultados
1 -
18
de 18
1
Próxima >
>>